Meeting of the Board of Directors for the approval of the draft separate financial statements and consolidated financial statements at 31 December 2025.
Annual general Shareholders’ Meeting for the approval of the financial statements at 31 December 2025.
Meeting of the Board of Directors for the approval of the half-yearly financial report at 30 June 2026